EFFECT OF DOXORUBICIN AND DAUNORUBICIN ON THE ACTIVITY OF ACETYLCHOLINESTERASE IN ACUTE LYMPHOBLASTIC LEUKAMIA
AbstractBackground: Our study was based on the alteration in the Michaelis Mentin parameters ApparentMichaelis Constant (aKm) and Apparent Maximum Velocity (aVm), which reflects activity ofactylcholinesterase (AChE). This activity decreases in Acute Lymphoblastic Leukaemia (ALL). Thisdecrease in aKm and aVm values shows bad prognosis. Similarly the anticancer drugs likeDaunorubicin and Doxorubicin further decreases the aKm and aVm values which worsen theprognosis. The objective of this study was to determine and compare the extent of inhibition ofAcetylecholine Esterase by Daunorubicin and Doxorubicin in ALL. Methods: Study of 100 patientsincluding both male and female children who’s age ranged from 4 to 8 years and were adviseddoxorubicin and daunorubicin separately were tested by Ellman’s method using acetylcholine iodide assubstrate and 5,5-dithiobis 2-nitrobenzine as a colour reagent regardless of dose regimen i.e. (once in 3week, small dose per week or a continuous infusion for 72 to 96 hours. Results: In this study theMichaelis Mentin parameters Apparent Michaelis Constant (aKm) and Apparent Maximum Velocity(aVm) of the enzyme were estimated both in normal individuals and in the patients and also duringtreatment with daunorubicin and doxorubicin. The value of Michaelis Mentin parameters, aKm, aVmand percentage activity of the enzyme in normal individual are 23, 70, and 100 respectively. The valuesof aKm, aVm and percentage activity of the enzyme were also estimated in the patients before and aftertreatment. The values of aKm and aVm in patients of acute lymphoblastic leukaemia and percentageactivity of enzyme is decreased. After the treatment with daunorubicin and doxorubicin the values andactivity is further decreased. Conclusion: We conclude that the drugs under study both decrease theenzyme activity but daunorubicin inhibits the enzyme more than doxorubicin.Keywords: Doxorubicin, daunorubicin, acetylcholinestrase
Metz J, Bradlow BA, Lewis SM, Dacie JV. The
acetylcholinesterase activity of the erythrocytes in
paroxysmal nocturnal haemoglobinuria in relation to the
severity of the disease. Br J Haematol 1960;6:372–80.
Low MG, Finean B. Non-lytic release of Ach. E from
erythrocytes by a phosphatidy inositol specific phosphatase
C. FEBS Lett 1977;82:143–6.
Stock TL. The organization of protein in the human red blood
cell membrane J Cell Biol l974;62(1):1–19.
Mabood SF. Kinetic characteristic of Ach E. of erythrocyte
of warm and cold blooded species of vertebrates. Pak J Sci
Ind Res 1981:24:127–34.
J Ayub Med Coll Abbottabad 2011;23(2)
Ahmad N, Hidayatullah, Khan ZM, Khan IA, Mabood SF.
Kinetic alteration in Michaclis Menten Parameters of Human
erythrocytes acetylcholinesterase in Diabetes MeIlitus. J
Chem Soc Pak 1987;9:623–6.
Sirchia G, Ferrone S, Mercuriall F, Zanella. Red cell
Acetylcholinesterase activity in autoimmune haemolytic
Anaemia. Br J Haematol 1970;19:411–5.
Habib N, Mabood SF, Akhtar MA. Kinetic-changes of
cholinesterase during the human menstrual cycle. J Animal
Sci Pak 1982;4(3–4):9.
Mabood SF, Habib N, Ghani S, Akhtar MA. Diurnal changes
in michaelis Menten Parameters of Human erythrocytes.
Acetylcholinesterase in pregnancy. J Animal Sci 1983;4:140.
Kaplay SS. Some Modified properties of human erythrocyte
Acetylcholinesterase in protein calorie different subjects.
Indian J Biochem Biophsy 1975;12:284–6.
Hidayatullah, Khan ZM, Mabood SF. Characterization of
AchE in spleenomagaly J Chem Soc Pak 1990;12(1):27.
Mohammad S, Mabood SF, Inayat-ur-Rahman, Sattar A,
Mustafa A. Estimation of Ach.E activity in addiction. J
Postgrad Med Ins 1994;8(2):67–71.
Schrier SL. Human erythrocyte membrane enzymes: Current
status and clinical correlation. Blood 1977;50:227–37.
Ogiso T, Takatsuki Y, Kato Y. Correlation between
cetylcholinesterase inhibition by drugs and their LD 50.
Nihon Yakurigaku Zasshi 1974;70:579–88.
Ellman GL, Couliny KD, Andres VV Jr, Featherstone RM. A
new and rapid calorimetric determination of Ach. activity
Biochem. Pharmacal 1961;7:88–95.